Damage effect and mechanisms of cyclophosphamide to human neuroblastoma SH-SY5Y cells

OBJECTIVE To investigate the damage effect and mechanisms of cyclophosphamide(CTX)and its active metabolite derivative 4-hydroperoxycyclophosphamide(4-HC)to human neuroblas⁃toma SH-SY5Y cells.METHODS SH-SY5Y cells were treated with CTX[0(cell control),0.01,0.1,1,5,10,20,40 and 80 mmol·L^(-1)]and 4-HC[0(cell control),0.01,0.1,1,5,10,20,40 and 80μmol·L^(-1)]for 48 h.Cell confluence and morphology were observed by the IncuCyte ZOOM system.Cell viability was assessed by CCK-8 assay.Lactate dehydrogenase(LDH)release was measured by LDH assay kit.SH-SY5Y cells were treated with CTX(0,1,5,10 and 20 mmol·L^(-1))and 4-HC(0,1,5,10 and 20μmol·L^(-1))for 48 h before cell proliferation was analyzed by 5-ethynyl-2′-deoxyuridine(EdU)staining assay.Immunofluorescence was employed to assess the levels of the DNA double-strand break markerγ-H2AX and to evaluate changes in mitochondrial membrane potential.SH-SY5Y cells were treated with CTX(0,1,5 and 10 mmol·L^(-1))and 4-HC(0,1,5 and 10μmol·L^(-1))for 48 h,and the alterations in glycolysis and oxidative phosphorylation levels were analyzed using the Seahorse XFe96 Analyzer.RESULTS Compared with the cell control group,cell confluence and cell viability were significantly reduced in the CTX and 4-HC groups(P<0.01),and the half-maximal inhibitory concentrations(IC50)for CTX and 4-HC were 4.44 mmol·L^(-1) and 4.78μmol·L^(-1),respectively.The release rate of LDH was signif⁃icantly increased while the percentage of EdU+cells was significantly reduced in the CTX and 4-HC groups(P<0.01).The percentage ofγ-H2AX+cells was significantly increased and mitochondrial membrane potential significantly decreased in the CTX and 4-HC group(P<0.05).Treatment with CTX and 4-HC resulted in reduced levels of maximum glycolytic capacity,glycolytic reserve,maximal respi⁃ration,and ATP production(P<0.05).CONCLUSION CTX and 4-HC exert significant cytotoxic effects on SH-SY5Y cells by disrupting cell membrane structure,impeding cell proliferation,and reducing cell viability.The mechanisms underlying these effects may involve intracellular DNA damage,disturbance of energy metabolism and mitochondrial dysfunction.

Geraniol alleviates cyclophosphamide-induced cardiotoxicity in mice

Objective:To explore the effect of geraniol on cyclophosphamide-induced cardiotoxicity.Methods:Mice were divided into five groups:the control group,the cyclophosphamide group(200 mg/kg cyclophosphamide,i.p.on day 7),the group treated with geraniol 100 and 200 mg/kg from day 1 to day 14,along with a single dose of cyclophosphamide on day 7,and the geraniol alone group(200 mg/kg geraniol from day 1 to day 14).At the end of the study,animals were sacrificed,and blood and heart were collected and analyzed for biochemical,histopathological,and immunohistochemical changes.Results:Treatment with 200 mg/kg geraniol significantly reduced the levels of cardiac injury markers,malondialdehyde,and inflammatory and apoptotic markers,while increasing antioxidant activities in mice with cyclophosphamide-induced cardiotoxicity.Moreover,it remarkably alleviated histopathological aberrations in cardiac tissue.Conclusions:Geraniol attenuates cyclophosphamide-induced cardiotoxicity via antioxidant,anti-inflammatory,and antiapoptotic effects.

Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma:A single-center, prospective,single-arm clinical trial

Objective: Unresectable hepatocellular carcinoma(uHCC) continues to pose effective treatment options. The objective of this study was to assess the efficacy and safety of combining low-dose cyclophosphamide with lenvatinib, pembrolizumab and transarterial chemoembolization(TACE) for the treatment of uHCC.Methods: From February 2022 to November 2023, a total of 40 patients diagnosed with uHCC were enrolled in this small-dose, single-center, single-arm, prospective study. They received a combined treatment of low-dose cyclophosphamide with lenvatinib, pembrolizumab, and TACE. Study endpoints included progression-free survival(PFS), objective response rate(ORR), and safety assessment. Tumor response was assessed using the modified Response Evaluation Criteria in Solid Tumors(mRECIST), while survival analysis was conducted through KaplanMeier curve analysis for overall survival(OS) and PFS. Adverse events(AEs) were evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events(version 5.0).Results: A total of 34 patients were included in the study. The median follow-up duration was 11.2 [95% confidence interval(95% CI), 5.3-14.6] months, and the median PFS(mPFS) was 15.5(95% CI, 5.4-NA) months.Median OS(mOS) was not attained during the study period. The ORR was 55.9%, and the disease control rate(DCR) was 70.6%. AEs were reported in 27(79.4%) patients. The most frequently reported AEs(with an incidence rate >10%) included abnormal liver function(52.9%), abdominal pain(44.1%), abdominal distension and constipation(29.4%), hypertension(20.6%), leukopenia(17.6%), constipation(17.6%), ascites(14.7%), and insomnia(14.7%). Abnormal liver function(14.7%) had the most common grade 3 or higher AEs.Conclusions: A combination of low-dose cyclophosphamide with lenvatinib, pembrolizumab, and TACE is safe and effective for u HCC, showcasing a promising therapeutic strategy for managing uHCC.

Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway

BACKGROUND Parthenolide(PTL),a sesquiterpene lactone derived from the medicinal herb Chrysanthemum parthenium,exhibits various biological effects by targeting NF-kB,STAT3,and other pathways.It has emerged as a promising adjunct therapy for multiple malignancies.AIM To evaluate the in vitro and in vivo effect of PTL on cyclophosphamide(CTX)metronomic chemotherapy.METHODS The cytotoxicity of PTL and CTX on Lewis lung cancer cells(LLC cells)was assessed by measuring cell activity and apoptosis.The anti-tumor efficiency was evaluated using a tumor xenograft mice model,and the survival of mice and tumor volume were monitored.Additionally,the collected tumor tissues were analyzed for tumor microenvironment indicators and inflammatory factors.RESULTS In vitro,PTL demonstrated a synergistic effect with CTX in inhibiting the growth of LLC cells and promoting apoptosis.In vivo,metronomic chemotherapy com-bined with PTL and CTX improved the survival rate of tumor-bearing mice and reduced tumor growth rate.Furthermore,metronomic chemotherapy combined with PTL and CTX reduced NF-κB activation and improved the tumor immune microenvironment by decreasing tumor angiogenesis,reducing Transforming growth factorβ,andα-SMA positive cells.CONCLUSION PTL is an efficient compound that enhances the metronomic chemotherapy effects of CTX both in vitro and in vivo,suggesting its potential as a supplementary therapeutic strategy in metronomic chemotherapy to improve the chemotherapy effects.

Establishment of a Mouse Thrombocytopenia Model Induced by Cyclophosphamide

An experiment was conducted to compare the effects of two mouse thrombocytopenia models induced by cyclophosphamide at two different administration routes to determine a proper cyclophosphamide administration route that could cause stable thrombocytopenia. A suitable drug dosage that could induce thrombocytopenia in mouse efficiently with the definite administration route was then investigated. BALB/c mice were randomly divided into Normal, Model A and Model B groups. To Model A, 200 mg/kg of cyclophosphamide was given by vena caudalis injection as first dose and 30 mg/kg as maintenance dose by intraperitoneal injection at the following 6 days. To Model B, 150 mg/kg of cyclophosphamide was given by subcutaneous injection once a day for consecutive 3 days. All groups were under investigation for 15 days. The result suggested that a decrease in the number of blood platelets of Model B at the 7th day were significantly than that of Normal. Other platelet related indices like platelet distribution width, mean platelet volume and platelet-large cell ratio of Model B increased significantly in comparison with those of Normal group. The platelets count was reduced but fluctuated greatly, and more than half of the mice died in Model A. Therefore, subcutaneous injection of cyclophosphamide for 3 days was used for the cyclophosphamide dosage test. BALB/c mice were randomly divided into Normal, cyclophosphamide low dose （100 mg/kg）, medium dose （120 mg/kg） and high dose （140 mg/kg） groups. All groups were under investigation for 11 days. Though all 3 dosages successfully initiated thrombocytopenia as the platelets number dropped at the 7th day, the low dose was considered to be a suitable one that was of high efficacy and low toxicity. Thus, BALB/c mice challenged by subcutaneous injection of cyclophosphamide 100 mg/kg per day for 3 consecutive day is one simple, feasible and stable mouse thrombocytopenia model that could be used for pharmacodynamic test of the drugs which are supposed to have platelets increasing effect.

Protective Effect of phytolacca Acinosa Polysaccharides Ⅰ(PAP-Ⅰ)on Hematopoiesis in Cyclophosphamide-treated and 60￣Co-irradiated Mice

The protective effect of a kind of purified polysaccharides extracted from Radix of Phytolacca acinosa Roxb,with a molecular weight of 10 KDa,on hematopoiesis was investigated.Average survival time of mice treated with cyclophosphamide (CY) 300 mg/kg once alone was 13.3 ± 7.2d(n=7) however,average survival time of mice treated with CY 300 mg/kg in com-bination with PAP-1 10 mg/kg,3 times/wk was 36.7± 16.4d(n=7,P<0.01).PAP-1,ip had benefi-cial effect on the recovery of the CY induced decrease of peripheral leukocyte number,and the nu-cleated bone marrow cell(BMC)number and[3￣H]TdR uptaken by BMC induced by rmGM-CSF in S180 bearing mice treated with CY,In mice,after the first ip treatment with CY 100 mg/kg on d7,the peripheral leukocyte number decreased on d9 and recovered to normal level about d13 to d15. Such recovery was accelerated by administrating PAP-1,10mg/kg, 3 times/wk.A significant in-crease of the activity to form colony in spleen(colony-forming unit in spleen, CFU-S_8, CUF-S12) in mice irradiated with 550 rad 6O￣Co γ-rays and an enhancement of proliferative response of BMC to rmGM-CSF treated with PAP-1,10mg/kg,3 times/wk, ip were observed.After PAP-1,10 mg/kg,ip once,a significant increase in the number of peripheral blood leukocytes and a rise in the serum of colony stimulating factor(CSF) were also confirmed.The types of CSF in serum were M-CSF and other hematopoietic growth factors,which were confirmed by using McAb of IL-3, GM-CSF and PcAb of M-CSF. These beneficial effects of PAP-1 on hematopoiesis may be related to its activityinducing CSFs and other hematopoietic growth factors and warrant further evaluation of its use-fulness.

空中交通CPS结构特性及韧性评估

针对空中交通体系结构复杂、耦合性强、脆弱性高的特点,为缓解因受扰导致的级联失效现象,对其结构韧性进行研究。建立了空中交通信息物理系统(CPS)模型,提出同层度与层间度、同层介数与层间介数等指标,分析级联失效过程;提出空中交通CPS韧性的概念,并采用定量评估方法对受损能力和恢复能力进行度量;对比不同扰动-恢复策略下的空中交通CPS表现,制定最佳恢复策略,提高受扰时的韧性。以华东地区空中交通CPS为例进行分析,结果表明:空中交通CPS网络度分布服从幂率分布,介数服从指数分布;在基于介数度值扰动下,采用介数恢复策略可以有效提高受扰时空中交通CPS的韧性。

支持访问策略部分隐藏的CP-ABE方案

针对现有支持外包解密的基于密文策略的属性加密(CP-ABE)方案大多未考虑对密文访问策略的隐私保护,而部分支持策略隐藏的方案又存在访问策略匹配效率低的问题,提出一种支持访问策略隐藏且访问策略匹配效率较高的CP-ABE方案。该方案对属性值进行盲化处理并构造隐藏策略访问树,实现了访问策略的隐私保护;采用布隆过滤器对属性进行过滤与成员认证,从而快速找到满足访问策略的最小属性集,减少解密测试中的大量无效计算;利用强算力的云服务器进行外包计算,减少本地的解密开销。理论分析和实验结果分析均表明,所提方案可兼顾计算效率与策略隐私保护,访问策略匹配效率和加解密速度显著提升,本地解密时间被减少至常数级。安全性分析表明,所提方案不仅保护了外包访问策略的隐私性,还能抵御选择明文攻击。

3种平差基准下高速铁路CPⅢ平面控制网的精度分析

针对工程实际CPⅢ网复测中以CPⅡ进行约束平差出现大量CPⅢ点坐标超限的情况,提出合理的CPⅢ网平差方法,设计总长为4020 m的标准网和加密网两种CPⅢ平面网。建立重心、一点一长方向和一点一短方向3种平差基准,分别计算各基准下两种网形600 m间距CPⅢ点间的相对中误差,并与CPⅡ点相对中误差8 mm的规范规定进行比较。研究结果表明:两种网形在3种基准下,测距精度对点位相对精度影响均非常小,方向精度是影响点位相对精度的主要因素。在重心、一点一长方向(CPⅠ的间距)基准下,两种网形600 m间距CPⅢ点间的相对中误差均显著小于8 mm,高于CPⅡ的相对精度。

CPS-SPWM级联H桥激励的变压器铁耗快速计算方法

针对载波移相(CPS)正弦脉宽调制(SPWM)级联H桥激励的变压器,提出一种基于经典损耗分离模型的铁耗快速计算方法.首先,结合SPWM电压波形特征定义集总占空比,并推导其关于调制比的解析模型;其次,基于经典损耗分离模型和集总占空比,构建CPS-SPWM级联H桥的铁耗计算模型,该方法可以直接使用调制比、直流母线电压等参数对铁耗进行计算,从而避免传统方法中的谐波分析或者数值积分过程;再次,基于本文铁耗计算模型,提出了一种针对SPWM电压激励的有限元(FEM)仿真等效方法,最后,通过实验验证了本文计算方法的有效性.研究结果表明:等效仿真铁耗误差小于3.6%、仿真用时减少74.5%;最大铁耗计算误差为7.6%.

基于CP-DeepLabv3+的玉米根系图像分割

利用微根管技术可以直接监测植物根系动态生长,并获取清晰根系图像,但土壤环境复杂、颗粒不均匀、细根数量多,图像分割时容易造成根系不连续,将土壤背景误认为根系。针对以上问题,提出了CP-DeepLabv3+算法进行图像分割。该算法引入坐标注意力机制(coordinate attention, CA),更精确地获得分割目标信息,使得分割目标边缘更加连续;在ASPP特征提取模块加入条纹池化(strip pooling,SP)分支,避免在相距较远的位置之间建立不必要的连接,提高图像分割精度。利用CP-DeepLabv3+算法对玉米根系数据集进行测试,结果显示,平均交并比(mean intersection over union,MIoU)值为82.95%,平均像素精确度(mean pixel accuracy,MPA)值为92.47%,相比于原始DeepLabv3+模型分别提高了3.69%、4.44%,表明该算法可有效分割玉米根系,对图像特征提取具有实际意义。

基于可聚合PVSS和联盟链的密钥可公开验证MA-CP-ABE方案

针对基于门限的多机构密文策略属性基加密(MA-CP-ABE)存在属性颁发机构(AA)不可信、属性私钥正确性无法公开验证等问题,提出了一种基于可聚合PVSS和联盟链的密钥可公开验证MA-CP-ABE方案。基于ElGamal改进可聚合PVSS算法,实现系统主密钥分发的可公开验证;基于双线性映射和ElGamal加密,构造MA-CP-ABE属性私钥可公开验证方法,实现属性私钥及其子份额密文条件下的可公开验证;基于联盟链提出密钥可公开验证MA-CP-ABE方案,通过联盟链保证验证参数可信,通过智能合约实现自动化验证。正确性、机密性、鲁棒性和活性等分析表明,当总AA数量为n、门限值为t、恶意AA数量不超过t-1时,所提方案能够保证属性私钥的正确分发,且系统主密钥初始化的通信开销复杂度为O(tn)。

温度变化对CPⅢ平面测量结果的影响

目前我国高速铁路建设里程已达3万余公里,在全球首屈一指。在高铁建设过程中,轨道控制网(CPⅢ)测量是一项必不可少的工作。某高铁CPⅢ建网测量过程中,相同点位搭接时两次测量结果坐标较差较大,不满足规范搭接要求,需进行外业补测。本文对搭接不成功处的数据进行了分析,认为两次测量温差较大可能是导致搭接不成功的原因之一,温度变化会对CPⅢ测量结果产生影响。同时,梁体宽度确定时引入混凝土膨胀系数计算得到的梁体宽度变化值与实测值互差较小,均未超过0.7 mm,验证了本文的观点。根据气温变化调整补测时间后,数据成果满足规范要求。最后通过定量分析得出,若将梁体宽度变化阈值设置为±2 mm,梁体宽度为9.25 m时,两次测量温差不应超过-21.6℃~21.6℃;梁体宽度为12.20 m时,两次测量温差不应超过-16.4℃~16.4℃。

Protective effect of ascorbic acid on cyclophosphamide induced testicular gametogenic and androgenic disorders in male rats

Aim:To study the detrimental effects of cyclophosphamide on the testicular androgenic and gametogenic activities through endocrine inhibition and/or induction of oxidative stress in male albino rats and to evaluate the protective effect of ascorbic acid.Methods:The testicular△^(5),3β-hydroxysteroid dehydrogenase(HSD),17β-HSD,peroxidase and catalase activities along with the levels of malondialdehyde(MDA)and conjugated dienes in testicular tissue were measured for the evaluation of testicular oxidative stress.The plasma testosterone(T)level was measured by immunoassay.Various germ cells at stageⅦof spermatogenic cycle were quantified from testicular stained sections.Results:Cyclophosphamide treatment results in a significant inhibition in the testicular△^(5),3β-HSD and 17β-HSD activities,a decrease in plasma T level and a diminution in the counts of various germ cells.Moreover,this treatment was also associated with a significant inhibition of the peroxidase and catalase activities along with high levels of MDA and conjugated dienes in the testis.All these changes were reversed by ascorbic acid co-administration.Conclusion:Cyclophosphamide treatment at the dosage used caused testicular gametogenic and androgenic disorders as well as induced testicular oxidative stress that can be reversed by ascorbic acid co-administration.

莫斯顿互惠式CP教学法对神经外科护理实习生的带教效果观察

目的:研究莫斯顿互惠式CP教学法在神经外科护理实习生带教中的应用效果。方法:选取神经外科护理实习生92人作为研究对象,随机抽取46人为对照组,46人为试验组,分别应用传统教学法与莫斯顿互惠式CP教学法进行带教。对两组护理实习生进行出科考试和核心胜任力评价,数据进行统计学分析。结果:试验组护理实习生的出科考试成绩、核心胜任力评分和素质水平评分均明显高于对照组,P<0.05。结论:莫斯顿互惠式CP教学法不仅可提高神经外科护理实习生的出科考试成绩,还能增强护理实习生的核心胜任力与素质水平。

Immune enhancement effect of an herb complex extract through the activation of natural killer cells and the regulation of cytokine levels in a cyclophosphamide-induced immunosuppression rat model

Objective: To investigate the effects of a herb complex extract(HCE) prepared from Cornus officinalis Sieb. Et Zucc., Eriobotrya japonica Lindley, and olive leaves on immune response of mouse spleen NK cells in vitro and in vivo analysis. Methods: The activity of natural killer(NK) cells was measured in splenocytes and YAC-1 cells. Mice were immunosuppressed using cyclophosphamide(5 mg/kg body weight). Three different doses of HCE(200, 400, and 800 mg/kg body weight) and red ginseng extract(800 mg/kg body weight) which was used as standard immunomodulatory herb were administered orally for 4 weeks. The body weight, dietary, water intake, organs(liver, thymus, and spleen) weight, completed blood count, and cytokines(tumor necrosis factor alpha, interferon gamma, and interleukin-2) production was measured. Results: At the maximum concentration of HCE, the activity of NK cells was increased by 48.5%. HCE increased liver, spleen, and thymus weights without altering numbers of white blood cells, lymphocytes, and neutrophils in a cyclophosphamide-induced immunosuppression rat model. However, HCE recovered the inhibited cytokine expression; HCE(800 mg/kg) increased cytokines levels. The results indicate the immune enhancement potential of this HCE. Conclusion: The HCE enhances immunity by increasing NK cell activity, regulating cytokine levels, and maintaining spleen weight. Therefore, it may be used as a potential immunity enhancer.

Nephroprotective effect of Murraya koenigii on Cyclophosphamide induced nephrotoxicity in rats

Objective: To evaluate the nephroprotective effect of defatted mehtanolic extract and aqueous extract of Murraya koenigii against Cyclophosphamide drug. Methods: Nephrotoxicity was induced by Cyclophosphamide in 7 d at 150 mg/kg body weight through intraperitoneal route in rat model. Nephroprotective activity of Murraya koenigii(M. koenigii) extract(100 mg/kg and 200 mg/kg in intraperitoneal route) was measured, including nephrological source, oxidative stress parameters like superoxide dismutase, glutathione, the lipid peroxide and in vivo assay like blood urea nitrogen, creatinine were determined and analyzed by One way analysis of variance followed by Tukey's test. Results: The study result showed that important phytochemicals such as carbohydrates, flavonoids, tannin, alkaloids, glycosides, protein and steroids were found to be present in the extract of M. koenigii. The renal function markers like blood urea nitrogen and ceatinine level were found to be decreased significantly by M. koenigii extract treatment. A significant difference was found to be at P<0.01. Conclusions: The present study reveals the protective role of M. koenigii extract against Cyclophosphamide induced nephrotoxicity.

UPLC-Q-TOF/MS-based metabolomics reveals modulatory effects of Mesona chinensis Benth polysaccharide in liver injury mice induced by cyclophosphamide

The main purpose of this study was to investigate the improvement effect of Mesona chinensis Benth polysaccharide(MP)on cyclophosphamide(CTX)induced liver injury in mice.To explore metabolic profile of liver tissue and feces among normal group,CTX-induced group and MP management group based on metabolomics method by using UPLC-Q-TOF/MS.The results showed that MP could alleviate liver injury and promote the production of short chain fatty acids(SCFAs),with the best dose of 200 mg/kg·body weight(bw).The principal component analysis(PCA)and orthogonal partial least squares discriminant analysis(OPLSDA)scores plots of the liver and feces samples showed a clear separation among normal,model and highdose of MP(MPH).There were 18 endogenous metabolites in liver and 29 endogenous metabolites in feces,which were mainly involved in 8 metabolic pathways:taurine and hypotaurine metabolism,phenylalanine metabolism,α-linolenic acid metabolism,tricarboxylic acid(TCA)cycle,phenylalanine,tyrosine and tryptophan biosynthesis,arachidonic acid metabolism,sphingolipid metabolism as well as tryptophan metabolism.Moreover,a common metabolite arachidonic acid was observed in liver and feces samples.These endogenous metabolites may be considered to be MP’s response to liver protection.It will help to further understand the mechanism of MP and provide a basis for further research.

Sesamol Alleviates the Cytotoxic Effect of Cyclophosphamide on Normal Human Lung WI-38 Cells via Suppressing RAGE/NF-κB/Autophagy Signaling

Cyclophosphamide(CYL)is a chemotherapeutic medication commonly used in managing various malignancies like breast cancer or leukemia.Though,CYL has been documented to induce lung toxicity.Mechanism of CYL toxicity is through oxidative stress and the release of damage-associated molecular patterns(DAMPs).Sesamol(SES)is a natural antioxidant isolated from Sesamum indicum and its effect against CYL-induced lung toxicity is not studied yet.This study aims to inves-tigate whether SES could prevent any deleterious effects induced by CYL on lung using normal human lung cells,WI-38 cell line,without suppressing its efficacy.Cells were pretreated with SES and/or CYL for 24 h,then cell viability was estimated by MTS and trypan blue assays.The mode of cell death was determined by AO/EB staining.Additionally,caspase-3 level,oxidative stress,and inflammatory markers were evaluated by colorimetric and ELISA techniques.qRT-PCR was performed to evaluate RAGE,NF-κB,and Beclin-1 mRNA-expression.CYL-treated WI-38 cells developed a significantly increased cell death with enhanced oxidative and RAGE/NF-κb/Autophagy signaling,which were all attenuated after pretreatment with SES.Thus,we concluded that SES offered a protective role against CYL-induced lung injury via suppressing oxidative stress and RAGE/NF-κB/Autophagy signaling,which is a natural safe therapeutic option against CYL toxicities.

基于CP-ABE算法的Fabric隐私保护模型

传统区块链系统缺少对区块数据的隐私保护。结合CP-ABE(基于属性加密的密文策略)算法和IPFS(星际文件系统),提出一种可以对Fabric区块链实现访问控制的隐私保护模型CP-PPM。CP-PPM的数据所有者可以灵活设置访问控制策略。仿真结果表明,与现有Fabric区块链系统相比,CP-PPM模型支持细粒度的访问控制,具有更强的隐私保护效果;CP-ABE算法可以安全初始化,对数据的加解密效率更高,同时增强了区块链系统的存储性能。